Cara Therapeutics, Inc. (22)
Browse by Contract Category
Contracts
-
Offer Letter with Ryan Maynard
(Filed With SEC on September 12, 2022)
-
License Agreement by and between Cara Therapeutics, Inc. and Vifor Fresenius Medical Care Renal Pharma Ltd
(Filed With SEC on August 8, 2022)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on May 9, 2022)
-
API Commercial Supply Agreement between Cara Therapeutics, Inc. and Polypeptide Laboratories S.A
(Filed With SEC on November 8, 2021)
-
Securities Purchase Agreement, dated October 15, 2020, by and between the Registrant and Vifor (International) Ltd
(Filed With SEC on February 25, 2021)
-
Amendment to Lease Agreement between the Registrant and Four Stamford Plaza Owner L.L.C. Stamford Lease, dated June 23, 2020
(Filed With SEC on August 10, 2020)
-
Cara Therapeutics, Inc. Severance Plan and Form of Participation Agreement
(Filed With SEC on March 1, 2022)
-
Form of Retention Agreement
(Filed With SEC on March 1, 2022)
-
Separation Agreement with Derek Chalmers
(Filed With SEC on November 3, 2021)
-
Employment Agreement with Christopher Posner
(Filed With SEC on November 3, 2021)
-
License Agreement, dated October 15, 2020, by and between Cara Therapeutics, Inc. and Vifor (International) Ltd
(Filed With SEC on February 25, 2021)
-
Employment Agreement with Thomas Reilly
(Filed With SEC on October 1, 2020)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on May 11, 2020)
-
Description of Securities
(Filed With SEC on February 27, 2020)
-
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under Cara Therapeutics, Inc. 2019 Inducement Plan
(Filed With SEC on November 20, 2019)
-
Form of Stock Option Grant Notice and Stock Option Agreement under Cara Therapeutics, Inc. 2019 Inducement Plan
(Filed With SEC on November 20, 2019)
-
Cara Therapeutics, Inc. 2019 Inducement Plan
(Filed With SEC on November 20, 2019)
-
Non-Exclusive License Agreement, dated August 20, 2019, between the Registrant and Enteris Biopharma, Inc
(Filed With SEC on November 5, 2019)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on August 7, 2019)
-
Underwriting Agreement, dated July 24, 2019
(Filed With SEC on July 29, 2019)
-
Separation and Consulting Agreement with Joseph Stauffer
(Filed With SEC on March 12, 2019)
-
Employment Agreement with Joana Goncalves
(Filed With SEC on March 12, 2019)
